Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Nicotinic acetylcholine receptors (nAChRs), particularly the α7 nAChR, are implicated in the pathophysiology of both autism spectrum disorder (ASD) and aggressive behavior. We explored the feasibility, tolerability, and preliminary efficacy of targeting nAChRs using transdermal nicotine to reduce aggressive symptoms in adults with ASD. Eight subjects were randomized in a double-blind crossover trial of 7 mg transdermal nicotine or placebo, each for 1 week. All participants tolerated nicotine treatment well. Five subjects contributed data to the primary outcome, Aberrant Behavior Checklist-Irritability (ABC-I) subscale change from baseline, which was improved by nicotine compared to placebo. Sleep ratings were also improved by nicotine and correlated with ABC-I improvement. These findings support further investigation of nAChR agonists for aggression and sleep in ASD.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394231 | PMC |
| http://dx.doi.org/10.1007/s10803-018-3536-7 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mobile Health Technology for Personalized Tobacco Cessation Support Among Cancer Survivors and Caregivers in Laos (Project SurvLaos): Protocol for a Pilot Randomized Controlled Trial.
JMIR Res Protoc
July 2025
TSET Health Promotion Research Center, Stephenson Cancer Center, University of Oklahoma Health Sciences, Oklahoma City, OK, United States.
Background: Tobacco use remains a major cause of preventable deaths and evidence suggests that smoking cessation offers considerable benefits for patients with and survivors of cancer. In the Lao People's Democratic Republic (Lao PDR), approximately 60% of male patients and 15% of female patients with cancer smoke cigarettes. Nevertheless, there is no tobacco treatment program for this population.
View Article and Find Full Text PDFEffect of perioperative transdermal nicotine patch on postoperative pain: A systematic review and meta-analysis.
Indian J Anaesth
July 2025
Department of Orthopaedics, AIIMS, New Delhi, India.
Background And Aims: Nicotine replacement therapy (NRT) has emerged as a potential intervention for managing perioperative pain. However, their effectiveness remains unclear, as previous studies neither considered the effect of the route of administration nor differentiated the effect between smokers and non-smokers. This systematic review and meta-analysis aimed to determine the effect of a perioperative transdermal nicotine patch on postoperative pain in both smokers and non-smokers compared with a placebo.
View Article and Find Full Text PDFMultimodal in vitro characterization techniques for assessing the adhesion of transdermal patches: A proof-of-concept study.
Eur J Pharm Biopharm
September 2025
Department of Pharmaceutical Sciences, Irma Lerma Rangel College of Pharmacy, Texas A&M University, Kingsville, TX, USA. Electronic address:
Adhesion is a critical factor in determining the quality, efficacy, and safety of transdermal patches. The adhesive properties directly influence drug permeation and flux, especially for matrix system patches. For potent therapeutics, the strength of adhesion and any minor tampering during wear can significantly impact the patch's in vivo performance.
View Article and Find Full Text PDFSimulating early steps in nicotine dependence: Pharmacokinetics, activation, and chaperoning of nicotinic receptors.
Mol Pharmacol
April 2025
Division of Biology, California Institute of Technology, Pasadena, California. Electronic address:
Nicotine App is a publicly accessible web-based simulator for the pharmacokinetics and pharmacodynamics of human smoking or vaping. The simulator exploits observations that nicotine has nearly equal concentrations in the plasma, cerebrospinal fluid, and endoplasmic reticulum, with time delays of just a few seconds. The simulations describe 2 nicotine-dependent processes.
View Article and Find Full Text PDFLong COVID - a critical disruption of cholinergic neurotransmission?
Bioelectron Med
February 2025
Department of Nuclear Medicine, University of Leipzig Medical Centre, Leipzig, 04103, Germany.
Background: Following the COVID-19 pandemic, there are many chronically ill Long COVID (LC) patients with different symptoms of varying degrees of severity. The pathological pathways of LC remain unclear until recently and make identification of path mechanisms and exploration of therapeutic options an urgent challenge. There is an apparent relationship between LC symptoms and impaired cholinergic neurotransmission.
View Article and Find Full Text PDF